News

OSSIANIX USES SHARK-DERIVED ANTIBODIES TO CROSS THE BBB

OSSIANIX USES SHARK-DERIVED ANTIBODIES TO CROSS THE BBB NeuroInsights 1st February 2016 Ossianix was founded in 2012 by Frank Walsh, Corey Goodman and Lynn Rutkowski, distinguished neuroscientists with extensive academic careers and senior level experience in the pharmaceutical industry. NeuroInsights caught up with Ossianix’s CEO Frank Walsh to discuss their innovative approach to crossing the blood-brain barrier. During Walsh’s tenure at Wyeth, it became apparent to him that biological approaches…

Read more